32
Growth Score in past quarter
pts
Heat Score 32 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Aros Pharma ApS develops therapies for reducing the pain associated with Irritable Bowel Syndrome (IBS)
About the Company
Aros Pharma is developing a new effective therapy reducing the pain associated with Irritable Bowel Syndrome (IBS). The company has acquired all rights to a new chemical entity that can negatively modulate the activity of acid sensors in the gastrointestinal tract. These acid sensors are believed to play a central role in pain associated with IBS.
